UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Primary ossifying fibroma of the proximal phalanx in a horse

Equine veterinary education, 2020-06, Vol.32 (6), p.O40-O44

2020

Volltextzugriff (PDF)

Metabolic gene profile in early human fetal heart development

Molecular human reproduction, 2014-07, Vol.20 (7), p.690-700

2014

Volltextzugriff (PDF)

Differential changes in gene expression in human brain during late first trimester and early second trimester of pregnancy

Prenatal diagnosis, 2014-05, Vol.34 (5), p.431-437

2014

Volltextzugriff (PDF)

Differential changes in gene expression in human brain during late first trimester and early second trimester of pregnancy: Differential changes in gene expression in first and second trimesters of pregnancy

Prenatal diagnosis, 2014-05, Vol.34 (5), p.431-437

2014

Volltextzugriff (PDF)

ECHOCARDIOGRAPHY PARAMETERS OF INCREASED FILLING PRESSURE AFTER ACUTE MYOCARDIAL INFARCTION IN HYPERTENSIVE PATIENTS: PP.23.237

Journal of hypertension, 2011-06, Vol.29, p.e362

2011

Volltextzugriff (PDF)

Evaluation of delayed neurotoxicity and dose-response relationships of phosphate esters in the adult hen

Toxicology and applied pharmacology, 1977-01, Vol.41 (2), p.291-304

1977

Volltextzugriff (PDF)

Caffeine Evaluation, Identification of Caffeine as Natural or Synthetic

Journal of agricultural and food chemistry, 1961-09, Vol.9 (5), p.397-401

1961

Volltextzugriff (PDF)

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

The New England journal of medicine, 2010-02, Vol.362 (5), p.387-401

2010

Volltextzugriff (PDF)

Neuroimaging predictors of transition to psychosis—A systematic review and meta-analysis

Neuroscience and biobehavioral reviews, 2010-07, Vol.34 (8), p.1207-1222

2010

Volltextzugriff (PDF)

Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study

Lancet neurology, 2022-03, Vol.21 (3), p.246-257

2022

Volltextzugriff (PDF)

Comparing the mechanical response of di‐, tri‐, and tetra‐functional resin epoxies with reactive molecular dynamics

Journal of polymer science. Part B, Polymer physics, 2018-02, Vol.56 (3), p.255-264

2018

Volltextzugriff (PDF)

Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2013-06, Vol.381 (9884), p.2167-2175

2013

Volltextzugriff (PDF)

Evaluation of Patients Treated with Natalizumab for Progressive Multifocal Leukoencephalopathy

The New England journal of medicine, 2006-03, Vol.354 (9), p.924-933

2006

Volltextzugriff (PDF)

Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results

Multiple sclerosis, 2010-02, Vol.16 (2), p.197-207

2010

Volltextzugriff (PDF)

Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial

Lancet neurology, 2021-11, Vol.20 (11), p.917-929

2021

Volltextzugriff (PDF)

The effects of antipsychotics on the brain: what have we learnt from structural imaging of schizophrenia?--a systematic review

Current pharmaceutical design, 2009-08, Vol.15 (22), p.2535-2549

2009

Volltextzugriff (PDF)

Standardized MR imaging protocol for multiple sclerosis : Consortium of MS centers consensus guidelines

AJNR. American journal of neuroradiology, 2006-02, Vol.27 (2), p.455-461

2006

Volltextzugriff (PDF)

Dopant precursor adsorption into single-dimer windows: Towards guided self-assembly of dopant arrays on Si(100)

Chemical physics letters, 2022-01, Vol.787, p.139258, Article 139258

2022

Volltextzugriff (PDF)

MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis

Trials, 2019-05, Vol.20 (1), p.263-263, Article 263

2019

Volltextzugriff (PDF)

Oral fingolimod (FTY720) in multiple sclerosis: two-year results of a phase II extension study

Neurology, 2009-01, Vol.72 (1), p.73-79

2009

Volltextzugriff (PDF)

Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study

Lancet neurology, 2012-05, Vol.11 (5), p.420-428

2012

Volltextzugriff (PDF)

Multiscale thermal modeling of cured cycloaliphatic epoxy/carbon fiber composites

Journal of applied polymer science, 2018-07, Vol.135 (25), p.n/a

2018

Volltextzugriff (PDF)

Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECTION): a multicentre, randomised, double-blind extension trial

Lancet neurology, 2014-05, Vol.13 (5), p.472-481

2014

Volltextzugriff (PDF)

The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL

Journal of neurology, 2009-03, Vol.256 (3), p.405-415

2009

Volltextzugriff (PDF)

1 – 25 von 152

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(124)
Mit Volltextzugriff
(112)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(78)
Life Sciences & Biomedicine
(67)
Humans
(65)
Female
(50)
Male
(49)
Adult
(45)
Neurosciences & Neurology
(39)
Biological And Medical Sciences
(38)
Clinical Neurology
(36)
Magnetic Resonance Imaging
(36)
Medical Sciences
(35)
Neurology
(34)
Middle Aged
(30)
Multiple Sclerosis
(23)
Adolescent
(19)
Brain - Pathology
(19)
Disease Progression
(18)
Treatment Outcome
(17)
Double-Blind Method
(16)
Multiple Sclerosis, Relapsing-Remitting - Drug Therapy
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Primary ossifying fibroma of the proximal phalanx in a horse

Metabolic gene profile in early human fetal heart development

Differential changes in gene expression in human brain during late first trimester and early second trimester of pregnancy

Differential changes in gene expression in human brain during late first trimester and early second trimester of pregnancy: Differential changes in gene expression in first and second trimesters of pregnancy

ECHOCARDIOGRAPHY PARAMETERS OF INCREASED FILLING PRESSURE AFTER ACUTE MYOCARDIAL INFARCTION IN HYPERTENSIVE PATIENTS: PP.23.237

Evaluation of delayed neurotoxicity and dose-response relationships of phosphate esters in the adult hen

Caffeine Evaluation, Identification of Caffeine as Natural or Synthetic

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

Neuroimaging predictors of transition to psychosis—A systematic review and meta-analysis

Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study

Comparing the mechanical response of di‐, tri‐, and tetra‐functional resin epoxies with reactive molecular dynamics

Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial

Evaluation of Patients Treated with Natalizumab for Progressive Multifocal Leukoencephalopathy

Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results

Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial

The effects of antipsychotics on the brain: what have we learnt from structural imaging of schizophrenia?--a systematic review

Standardized MR imaging protocol for multiple sclerosis : Consortium of MS centers consensus guidelines

Dopant precursor adsorption into single-dimer windows: Towards guided self-assembly of dopant arrays on Si(100)

MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis

Oral fingolimod (FTY720) in multiple sclerosis: two-year results of a phase II extension study

Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study

Multiscale thermal modeling of cured cycloaliphatic epoxy/carbon fiber composites

Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECTION): a multicentre, randomised, double-blind extension trial

Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis

The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL

Suchergebnisse filtern